-transparent.png){kind=logo}
Pharmacokinetics of single dose (25 mg i.m.) of imipramine was studied in geriatric and young adult patients with mood disorders requiring antidepressant treatment. Imipramine and its principal metabolites were determined by means of a high performance liquid chromatography method with electrochemical detection. Serum concentrations analysis was performed according to a bicompartmental open model. A relationship between age and kinetic parameters such as area under the curve, elimination phase constant, half-life and total body clearance was observed. Significant differences were demonstrated between elderly and young adult patients when comparing these parameters. It is concluded that geriatric patients treated with imipramine should receive doses of about 60% of those of young adults.
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
July 1980,
Psychopharmacology bulletin,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
April 1985,
Journal of clinical psychopharmacology,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
October 1975,
Psychopharmacology bulletin,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
February 1988,
Journal of clinical psychopharmacology,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
April 1990,
Psychiatry research,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
October 1984,
The Journal of clinical psychiatry,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
November 1985,
Biological psychiatry,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
May 1999,
Pharmacopsychiatry,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
September 1973,
The British journal of psychiatry : the journal of mental science,
P Benetello, and
M Furlanut, and
G Zara, and
M Baraldo
April 1989,
Biological psychiatry,
